{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T07:07:19Z","timestamp":1785395239152,"version":"3.55.0"},"reference-count":61,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2012,11,29]],"date-time":"2012-11-29T00:00:00Z","timestamp":1354147200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"DOI":"10.1371\/journal.pntd.0001896","type":"journal-article","created":{"date-parts":[[2012,11,29]],"date-time":"2012-11-29T22:40:16Z","timestamp":1354228816000},"page":"e1896","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":78,"title":["Identification of Compounds with Anti-Proliferative Activity against Trypanosoma brucei brucei Strain 427 by a Whole Cell Viability Based HTS Campaign"],"prefix":"10.1371","volume":"6","author":[{"given":"Melissa L.","family":"Sykes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan B.","family":"Baell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel","family":"Kaiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Chatelain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah R.","family":"Moawad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danny","family":"Ganame","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Robert","family":"Ioset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicky M.","family":"Avery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2012,11,29]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/1476-072X-9-57","article-title":"The Atlas of human African trypanosomiasis: a contribution to global mapping of neglected tropical diseases","volume":"9","author":"PP Simarro","year":"2010","journal-title":"Int J Health Geogr"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"e333","DOI":"10.1371\/journal.pntd.0000333","article-title":"The burden of human African trypanosomiasis","volume":"2","author":"EM Fevre","year":"2008","journal-title":"PLoS Negl Trop Dis"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1210\/jcem-65-1-153","article-title":"Effects of suramin on the function and structure of the adrenal cortex in the cynomolgus monkey","volume":"65","author":"P Feuillan","year":"1987","journal-title":"J Clin Endocrinol Metab"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s00436-002-0799-9","article-title":"Arsenicals (melarsoprol), pentamidine and suramin in the treatment of human African trypanosomiasis","volume":"90","author":"AJ Nok","year":"2003","journal-title":"Parasitol Res"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"966","DOI":"10.3201\/eid1406.071266","article-title":"High failure rates of melarsoprol for sleeping sickness, Democratic Republic of Congo","volume":"14","author":"J Robays","year":"2008","journal-title":"Emerg Infect Dis"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.molbiopara.2003.07.004","article-title":"Cloning and analysis of Trypanosoma cruzi lanosterol 14alpha-demethylase","volume":"132","author":"FS Buckner","year":"2003","journal-title":"Mol Biochem Parasitol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0065-308X(08)60410-8","article-title":"The treatment of human African trypanosomiasis","volume":"33","author":"J Pepin","year":"1994","journal-title":"Adv Parasitol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1086\/432576","article-title":"Eflornithine is safer than melarsoprol for the treatment of second-stage Trypanosoma brucei gambiense human African trypanosomiasis","volume":"41","author":"F Chappuis","year":"2005","journal-title":"Clin Infect Dis"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0166-6851(02)00282-7","article-title":"Protein farnesyl and N-myristoyl transferases: piggy-back medicinal chemistry targets for the development of antitrypanosomatid and antimalarial therapeutics","volume":"126","author":"MH Gelb","year":"2003","journal-title":"Mol Biochem Parasitol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1021\/ol0160506","article-title":"Trypanosome and animal lanosterol synthases use different catalytic motifs","volume":"3","author":"BM Joubert","year":"2001","journal-title":"Org Lett"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1017\/S1462399409001252","article-title":"Trypanocidal drugs: mechanisms, resistance and new targets","volume":"11","author":"SR Wilkinson","year":"2009","journal-title":"Expert Rev Mol Med"},{"key":"ref12","unstructured":"WHO (2011) WHO Model list of essential medicines. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/wwwwhoint\/medicines\/publications\/essentialmedicines\/en\/indexhtml\" xlink:type=\"simple\">http:\/\/wwwwhoint\/medicines\/publications\/essentialmedicines\/en\/indexhtml<\/ext-link>."},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1086\/522982","article-title":"Nifurtimox-eflornithine combination therapy for second-stage Trypanosoma brucei gambiense sleeping sickness: a randomized clinical trial in Congo","volume":"45","author":"G Priotto","year":"2007","journal-title":"Clin Infect Dis"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0140-6736(09)61163-6","article-title":"NECT trial: more than a small victory over sleeping sickness","volume":"374","author":"J Opigo","year":"2009","journal-title":"Lancet"},{"key":"ref15","first-page":"876","article-title":"Diamidines for human African trypanosomiasis","volume":"11","author":"MF Paine","year":"2010","journal-title":"Curr Opin Investig Drugs"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"4379","DOI":"10.1128\/AAC.00498-10","article-title":"Discovery of novel orally bioavailable oxaborole 6-carboxamides that demonstrate cure in a murine model of late-stage central nervous system african trypanosomiasis","volume":"54","author":"B Nare","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"e1151","DOI":"10.1371\/journal.pntd.0001151","article-title":"SCYX-7158, an orally-active benzoxaborole for the treatment of stage 2 human African trypanosomiasis","volume":"5","author":"RT Jacobs","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/nrd1470","article-title":"Can the pharmaceutical industry reduce attrition rates?","volume":"3","author":"I Kola","year":"2004","journal-title":"Nature Reviews drug discovery"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"e659","DOI":"10.1371\/journal.pntd.0000659","article-title":"A target-based high throughput screen yields Trypanosoma brucei hexokinase small molecule inhibitors with antiparasitic activity","volume":"4","author":"ER Sharlow","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"665","DOI":"10.4269\/ajtmh.2009.09-0015","article-title":"Development of an Alamar Blue viability assay in 384-well format for high throughput whole cell screening of Trypanosoma brucei brucei bloodstream form strain 427","volume":"81","author":"ML Sykes","year":"2009","journal-title":"Am J Trop Med Hyg"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/nrd1824","article-title":"Opportunities and challenges in antiparasitic drug discovery","volume":"4","author":"R Pink","year":"2005","journal-title":"Nat Rev Drug Discov"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"5421","DOI":"10.1046\/j.1432-1327.2000.01606.x","article-title":"Investigation of the Alamar Blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity","volume":"267","author":"J O'Brien","year":"2000","journal-title":"Eur J Biochem"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1021\/jm901137j","article-title":"New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays","volume":"53","author":"JB Baell","year":"2010","journal-title":"J Med Chem"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/108705719900400206","article-title":"A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays","volume":"4","author":"JH Zhang","year":"1999","journal-title":"J Biomol Screen"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/sj.embor.embor748","article-title":"The big and small of drug discovery. Biotech versus pharma: advantages and drawbacks in drug development","volume":"4","author":"A Moore","year":"2003","journal-title":"EMBO Rep"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1017\/S0031182000046540","article-title":"Cultivation of Trypanosoma brucei sspp. in semi-defined and defined media","volume":"67","author":"GA Cross","year":"1973","journal-title":"Parasitology"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"985","DOI":"10.2307\/3282883","article-title":"Continuous cultivation of Trypanosoma brucei blood stream forms in a medium containing a low concentration of serum protein without feeder cell layers","volume":"75","author":"H Hirumi","year":"1989","journal-title":"J Parasitol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0022-1759(94)90396-4","article-title":"A new rapid and simple non-radioactive assay to monitor and determine the proliferation of lymphocytes: an alternative to [3H]thymidine incorporation assay","volume":"170","author":"SA Ahmed","year":"1994","journal-title":"J Immunol Methods"},{"key":"ref29","first-page":"473","article-title":"A new fluorimetric assay for cytotoxicity measurements in vitro","volume":"3","author":"C Page","year":"1993","journal-title":"International Journal of Oncology"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1002\/j.1460-2075.1985.tb03772.x","article-title":"Cultivation in a semi-defined medium of animal infective forms of Trypanosoma brucei, T. equiperdum, T. evansi, T. rhodesiense and T. gambiense","volume":"4","author":"T Baltz","year":"1985","journal-title":"EMBO J"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0001-706X(97)00079-X","article-title":"The Alamar Blue assay to determine drug sensitivity of African trypanosomes (T.b. rhodesiense and T.b. gambiense) in vitro","volume":"68","author":"B Raz","year":"1997","journal-title":"Acta Trop"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1128\/AAC.40.11.2592","article-title":"Efficient technique for screening drugs for activity against Trypanosoma cruzi using parasites expressing beta-galactosidase","volume":"40","author":"FS Buckner","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1550-7408.1977.tb00987.x","article-title":"New culture medium for maintenance of tsetse tissues and growth of trypanosomatids","volume":"24","author":"I Cunningham","year":"1977","journal-title":"J Protozool"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S1383-5769(99)00020-3","article-title":"A simple colorimetric method to screen drug cytotoxicity against Leishmania using the dye Alamar Blue","volume":"48","author":"J Mikus","year":"2000","journal-title":"Parasitol Int"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1128\/AAC.16.6.710","article-title":"Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique","volume":"16","author":"RE Desjardins","year":"1979","journal-title":"Antimicrob Agents Chemother"},{"key":"ref36","doi-asserted-by":"crossref","unstructured":"Matile H, Pink JRL (1990) Plasmodium falciparum malaria parasite cultures and their use in immunology; Lefkovits I, Pernis B, editors. San Diego Academic Press.","DOI":"10.1016\/B978-0-12-442704-4.50021-9"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/0035-9203(83)90080-9","article-title":"Susceptibility of Plasmodium falciparum to five drugs: an in vitro study of isolates mainly from Thailand","volume":"77","author":"S Thaithong","year":"1983","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"4350","DOI":"10.1021\/jm020155c","article-title":"Do structurally similar molecules have similar biological activity?","volume":"45","author":"YC Martin","year":"2002","journal-title":"J Med Chem"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1111\/j.1537-2995.2005.00552.x","article-title":"Leishmania inactivation in human pheresis platelets by a psoralen (amotosalen HCl) and long-wavelength ultraviolet irradiation","volume":"45","author":"RT Eastman","year":"2005","journal-title":"Transfusion"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"5415","DOI":"10.1021\/jm050441z","article-title":"The protein farnesyltransferase inhibitor Tipifarnib as a new lead for the development of drugs against Chagas disease","volume":"48","author":"O Hucke","year":"2005","journal-title":"J Med Chem"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"4891","DOI":"10.1021\/jm049740z","article-title":"Assessment of the consistency of medicinal chemists in reviewing sets of compounds","volume":"47","author":"MS Lajiness","year":"2004","journal-title":"J Med Chem"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1747-0285.2006.00389.x","article-title":"Discovery of trypanocidal compounds by whole cell HTS of Trypanosoma brucei","volume":"67","author":"ZB Mackey","year":"2006","journal-title":"Chem Biol Drug Des"},{"key":"ref43","first-page":"156","article-title":"Mediation sans litigation in malpractice","volume":"16","author":"F Buckner","year":"2000","journal-title":"J Med Pract Manage"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1475-9292-5-3","article-title":"In vitro growth inhibition of bloodstream forms of Trypanosoma brucei and Trypanosoma congolense by iron chelators","volume":"5","author":"K Merschjohann","year":"2006","journal-title":"Kinetoplastid Biol Dis"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1128\/AAC.49.3.1076-1080.2005","article-title":"Synthesis and antileishmanial activities of novel 3-substituted quinolines","volume":"49","author":"AG Tempone","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"ref46","unstructured":"Berg A-L, Bhat R (2007) GSK-3 inhibitors for the treatment of osteoporosis. Sweden."},{"key":"ref47","unstructured":"Buhr K, Baik T-G (2004) Protein kinase modulators and method of use. United States."},{"key":"ref48","unstructured":"Burger M, Lindvall M, Han W, La J, Nishiguchi G, <etal>et al<\/etal>.. (2008) Pim kinase inhibitors and methods of their use. United States."},{"key":"ref49","unstructured":"Charrier J-D, Durrant S, Kay D, Knegtel R, MacCormick S, <etal>et al<\/etal>.. (2004) Pyrazine derivatives useful as inhibitors of ATR kinase and their preparation and use in the treatment of diseases. United States."},{"key":"ref50","unstructured":"Munchhof MJ (2004) Novel pyrazine compounds as transforming growth factor (TGF) compounds. United States."},{"key":"ref51","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1016\/j.bmcl.2008.11.106","article-title":"Discovery of oxazolo[4,5-b]pyridines and related heterocyclic analogs as novel SIRT1 activators","volume":"19","author":"JE Bemis","year":"2009","journal-title":"Bioorg Med Chem Lett"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1111\/j.1365-2958.2006.05553.x","article-title":"A sirtuin in the African trypanosome is involved in both DNA repair and telomeric gene silencing but is not required for antigenic variation","volume":"63","author":"S Alsford","year":"2007","journal-title":"Mol Microbiol"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"5851","DOI":"10.1093\/emboj\/cdg553","article-title":"A chromosomal SIR2 homologue with both histone NAD-dependent ADP-ribosyltransferase and deacetylase activities is involved in DNA repair in Trypanosoma brucei","volume":"22","author":"JA Garcia-Salcedo","year":"2003","journal-title":"EMBO J"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"5317","DOI":"10.1074\/jbc.M707613200","article-title":"Acetylation-dependent ADP-ribosylation by Trypanosoma brucei Sir2","volume":"283","author":"TM Kowieski","year":"2008","journal-title":"J Biol Chem"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1002\/mrc.2648","article-title":"Chemical shift assignment and conformational analysis of monoalkylated acylguanidines","volume":"48","author":"R Kleinmaier","year":"2010","journal-title":"Magn Reson Chem"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"6511","DOI":"10.1021\/jo900871a","article-title":"Characterization of the two fundamental conformations of benzoylureas and elucidation of the factors that facilitate their conformational interchange","volume":"74","author":"G Lessene","year":"2009","journal-title":"J Org Chem"},{"key":"ref57","unstructured":"Glick G, Ney G (2008) F1F0- ATPase inhibitors and related methods. United States."},{"key":"ref58","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1128\/AAC.00642-07","article-title":"The mitochondrion is a site of trypanocidal action of the aromatic diamidine DB75 in bloodstream forms of Trypanosoma brucei","volume":"52","author":"CA Lanteri","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/0003-9861(58)90383-7","article-title":"Antibiotics as tools for metabolic studies. I. A survey of toxic antibiotics in respiratory, phosphorylative and glycolytic systems","volume":"78","author":"HA Lardy","year":"1958","journal-title":"Arch Biochem Biophys"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1016\/j.bcp.2010.07.038","article-title":"Identification of a kappa-opioid agonist as a potent and selective lead for drug development against human African trypanosomiasis","volume":"80","author":"DC Jones","year":"2010","journal-title":"Biochem Pharmacol"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0166-6851(91)90164-2","article-title":"Differential expression of the oligomycin-sensitive ATPase in bloodstream forms of Trypanosoma brucei brucei","volume":"48","author":"EJ Bienen","year":"1991","journal-title":"Mol Biochem Parasitol"}],"updated-by":[{"DOI":"10.1371\/annotation\/cc952155-c929-4e4f-8fc0-43cb84c50452","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2013,1,22]],"date-time":"2013-01-22T00:00:00Z","timestamp":1358812800000}}],"container-title":["PLoS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pntd.0001896","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T05:52:21Z","timestamp":1594965141000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0001896"}},"subtitle":[],"editor":[{"given":"Eric","family":"Dumonteil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2012,11,29]]},"references-count":61,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2012,11,29]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0001896","relation":{"correction":[{"id-type":"doi","id":"10.1371\/annotation\/cc952155-c929-4e4f-8fc0-43cb84c50452","asserted-by":"object"}]},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,11,29]]}}}